Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China.

Chen, Yihui; Cao, Qiaozhi; Peng, Cong; Zhou, Bingjing; Jiang, Yu; Chen, Xiang; Li, Jie

Chen, Yihui; Cao, Qiaozhi; Peng, Cong; Zhou, Bingjing; Jiang, Yu; Chen, Xiang; Li, Jie.

Afiliação

Chen Y; Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
Cao Q; Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, 410008, China.
Peng C; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
Zhou B; Furong Laboratory, Changsha, 410008, China.
Jiang Y; Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
Chen X; Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, 410008, China.
Li J; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.

Front Med ; 2024 Jul 16.

Article em En | MEDLINE | ID: mdl-39012398

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google